• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

琥珀酸半醛脱氢酶缺乏症(SSADHD)发病生理机制中的肠道菌群失调。

Intestinal Dysbiosis as a component of pathophysiology in succinic semialdehyde dehydrogenase deficiency (SSADHD).

机构信息

Department of Pharmacotherapy, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, USA.

Department of Pharmacotherapy, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, USA.

出版信息

Mol Genet Metab. 2022 Jan;135(1):42-46. doi: 10.1016/j.ymgme.2021.11.355. Epub 2021 Dec 3.

DOI:10.1016/j.ymgme.2021.11.355
PMID:34896003
Abstract

Succinic semialdehyde dehydrogenase deficiency (SSADHD) is an inherited inborn error of the γ-aminobutyric acid (GABA) metabolism pathway. It results from mutations in the ALDH5A1 gene leading to elevated GABA, γ-hydroxybutyric acid (GHB), succinic semialdehyde (SSA), decreased glutamine and alterations in several other metabolites. The phenotype includes developmental and cognitive delays, hypotonia, seizures, neuropsychiatric morbidity and other nervous system pathologies. The composition of the intestinal flora of patients with SSADHD has not been characterized, and dysbiosis of the gut microbiome may unveil novel treatment paradigms. We investigated the gut microbiome in SSADHD using 16S ribosomal DNA sequencing and unmasked evidence of dysbiosis in both aldh5a1-deficient mice and patients with SSADHD. In the murine model, there was a reduction in α-diversity measurements, and there were 4 phyla, 3 classes, 5 orders, 9 families, and 15 genera that differed, with a total of 17 predicted metabolic pathways altered. In patients, there were changes in Fusobacterium, 3 classes, 4 orders, 11 families, and a predicted alteration in genes associated with the digestive system. We believe this is the first evaluation of microbiome structure in an IEM with a neurometabolic phenotype that is not treated dietarily.

摘要

琥珀酸半醛脱氢酶缺乏症(SSADHD)是一种γ-氨基丁酸(GABA)代谢途径的遗传性先天性错误。它是由 ALDH5A1 基因突变引起的,导致 GABA、γ-羟基丁酸(GHB)、琥珀酸半醛(SSA)升高,谷氨酰胺降低,以及其他几种代谢物的改变。表型包括发育和认知迟缓、张力减退、癫痫发作、神经精神发病率和其他神经系统病变。SSADHD 患者的肠道菌群组成尚未得到描述,肠道微生物组的失调可能揭示出新的治疗模式。我们使用 16S 核糖体 DNA 测序研究了 SSADHD 的肠道微生物组,并在 aldh5a1 缺陷型小鼠和 SSADHD 患者中揭示了微生物失调的证据。在小鼠模型中,α-多样性测量值降低,有 4 个门、3 个纲、5 个目、9 个科和 15 个属存在差异,共有 17 个预测的代谢途径发生改变。在患者中,梭杆菌属发生了变化,有 3 个纲、4 个目、11 个科和一个与消化系统相关的基因预测发生了改变。我们相信,这是首次对未经饮食治疗的具有神经代谢表型的 IEM 进行微生物组结构评估。

相似文献

1
Intestinal Dysbiosis as a component of pathophysiology in succinic semialdehyde dehydrogenase deficiency (SSADHD).琥珀酸半醛脱氢酶缺乏症(SSADHD)发病生理机制中的肠道菌群失调。
Mol Genet Metab. 2022 Jan;135(1):42-46. doi: 10.1016/j.ymgme.2021.11.355. Epub 2021 Dec 3.
2
Succinic semialdehyde dehydrogenase deficiency (SSADHD): Pathophysiological complexity and multifactorial trait associations in a rare monogenic disorder of GABA metabolism.琥珀酸半醛脱氢酶缺乏症(SSADHD):γ-氨基丁酸代谢罕见单基因疾病中的病理生理复杂性和多因素性状关联
Neurochem Int. 2016 Oct;99:72-84. doi: 10.1016/j.neuint.2016.06.009. Epub 2016 Jun 14.
3
Maternal glutamine supplementation in murine succinic semialdehyde dehydrogenase deficiency, a disorder of γ-aminobutyric acid metabolism.母鼠谷氨酸盐补充治疗琥珀酸半醛脱氢酶缺乏症,γ-氨基丁酸代谢紊乱。
J Inherit Metab Dis. 2019 Sep;42(5):1030-1039. doi: 10.1002/jimd.12107. Epub 2019 May 29.
4
Temporal metabolomics in dried bloodspots suggests multipathway disruptions in aldh5a1 mice, a model of succinic semialdehyde dehydrogenase deficiency.干血斑中的时间代谢组学表明,琥珀酸半醛脱氢酶缺乏症模型 aldh5a1 小鼠存在多途径紊乱。
Mol Genet Metab. 2019 Dec;128(4):397-408. doi: 10.1016/j.ymgme.2019.10.003. Epub 2019 Oct 31.
5
Rett syndrome (MECP2) and succinic semialdehyde dehydrogenase (ALDH5A1) deficiency in a developmentally delayed female.一名发育迟缓女性患雷特综合征(MECP2)和琥珀酰半醛脱氢酶(ALDH5A1)缺乏症。
Mol Genet Genomic Med. 2019 May;7(5):e629. doi: 10.1002/mgg3.629. Epub 2019 Mar 4.
6
Therapeutic relevance of mTOR inhibition in murine succinate semialdehyde dehydrogenase deficiency (SSADHD), a disorder of GABA metabolism.mTOR 抑制在鼠琥珀酸半醛脱氢酶缺乏症(SSADHD)中的治疗相关性,一种 GABA 代谢紊乱。
Biochim Biophys Acta Mol Basis Dis. 2017 Jan;1863(1):33-42. doi: 10.1016/j.bbadis.2016.10.009. Epub 2016 Oct 17.
7
A Missense Variant in Associated with Canine Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD) in the Saluki Dog.一种与萨路基猎犬琥珀酸半醛脱氢酶缺乏症(SSADHD)相关的错义变异。
Genes (Basel). 2020 Sep 2;11(9):1033. doi: 10.3390/genes11091033.
8
SSADH deficiency in an Italian family: a novel ALDH5A1 gene mutation affecting the succinic semialdehyde substrate binding site.意大利一个家族的 SSADH 缺乏症:一个影响琥珀酸半醛底物结合位点的新型 ALDH5A1 基因突变。
Metab Brain Dis. 2017 Oct;32(5):1383-1388. doi: 10.1007/s11011-017-0058-5. Epub 2017 Jun 29.
9
Enzyme Replacement Therapy for Succinic Semialdehyde Dehydrogenase Deficiency: Relevance in γ-Aminobutyric Acid Plasticity.琥珀酸半醛脱氢酶缺乏症的酶替代治疗:γ-氨基丁酸可塑性的相关性。
J Child Neurol. 2021 Nov;36(13-14):1200-1209. doi: 10.1177/0883073821993000. Epub 2021 Feb 24.
10
Novel mutations in two unrelated Italian patients with SSADH deficiency.两例意大利无关 SSADH 缺乏症患者中的新型突变。
Metab Brain Dis. 2019 Oct;34(5):1515-1518. doi: 10.1007/s11011-019-00453-w. Epub 2019 Jul 2.

引用本文的文献

1
Reduced evoked cortical beta and gamma activity and neuronal synchronization in succinic semialdehyde dehydrogenase deficiency, a disorder of γ-aminobutyric acid metabolism.琥珀酸半醛脱氢酶缺乏症(一种γ-氨基丁酸代谢紊乱疾病)中诱发的皮质β和γ活动以及神经元同步性降低。
Brain Commun. 2023 Oct 25;5(6):fcad291. doi: 10.1093/braincomms/fcad291. eCollection 2023.